GENEGENETIC TECHNOLOGIES LTD

Nasdaq genetype.com


$ 1.35 $ 0.04 (3.05 %)    

Wednesday, 10-Jul-2024 10:38:27 EDT
QQQ $ 501.30 $ 1.42 (0.28 %)
DIA $ 394.73 $ 1.79 (0.45 %)
SPY $ 558.83 $ 1.71 (0.31 %)
TLT $ 92.50 $ 0.03 (0.03 %)
GLD $ 219.91 $ -0.25 (-0.11 %)
$ 1.31
$ 1.31
$ 0.00 x 0
$ 1.46 x 100
$ 1.31 - $ 1.35
$ 1.23 - $ 23.65
9,942
na
1.01M
$ 1.37
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 genetype-announces-the-introduction-of-suite-of-genetic-risk-assessment-tests-to-canada-and-new-zealand

Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in genomics-based tes...

 genetic-technologies-reported-monday-genetype-identifies-795-of-people-tested-in-us-australia-are-at-risk-of-serious-disease

Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in genomics-based tes...

 genetype-stayhealthy-announce-landmark-distribution-agreement-for-multi-risk-test-to-a-broader-audience-in-the-online-pharmacy-channel-across-north-america

Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in genomics-based tes...

 gtg-launches-genetype-a-novel-comprehensive-risk-assessment-test-that-covers-100-of-women-at-risk-of-developing-breast-and-ovarian-cancer

Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in genomics-based tes...